- Home
- PERI vs ARCT Comparison
PERI vs ARCT Comparison
Compare PERI & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PERI
- ARCT
- Stock Information
- Founded
- PERI 1999
- ARCT 2013
- Country
- PERI Israel
- ARCT United States
- Employees
- PERI N/A
- ARCT N/A
- Industry
- PERI EDP Services
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- PERI Technology
- ARCT Health Care
- Exchange
- PERI Nasdaq
- ARCT Nasdaq
- Market Cap
- PERI 395.5M
- ARCT 444.5M
- IPO Year
- PERI 2006
- ARCT N/A
- Fundamental
- Price
- PERI $7.49
- ARCT $9.19
- Analyst Decision
- PERI Hold
- ARCT Strong Buy
- Analyst Count
- PERI 5
- ARCT 7
- Target Price
- PERI $10.33
- ARCT $57.80
- AVG Volume (30 Days)
- PERI 374.5K
- ARCT 430.2K
- Earning Date
- PERI 05-07-2025
- ARCT 03-06-2025
- Dividend Yield
- PERI N/A
- ARCT N/A
- EPS Growth
- PERI N/A
- ARCT N/A
- EPS
- PERI 0.25
- ARCT N/A
- Revenue
- PERI $498,286,000.00
- ARCT $152,310,000.00
- Revenue This Year
- PERI N/A
- ARCT N/A
- Revenue Next Year
- PERI $5.24
- ARCT $39.21
- P/E Ratio
- PERI $33.96
- ARCT N/A
- Revenue Growth
- PERI N/A
- ARCT N/A
- 52 Week Low
- PERI $7.47
- ARCT $9.18
- 52 Week High
- PERI $22.03
- ARCT $45.00
- Technical
- Relative Strength Index (RSI)
- PERI 36.52
- ARCT 25.34
- Support Level
- PERI $7.90
- ARCT $11.71
- Resistance Level
- PERI $8.56
- ARCT $13.41
- Average True Range (ATR)
- PERI 0.23
- ARCT 0.82
- MACD
- PERI -0.00
- ARCT -0.30
- Stochastic Oscillator
- PERI 1.29
- ARCT 0.00
About PERI Perion Network Ltd.
Perion Network Ltd is a technology company. It offers online advertising and search solutions to brands, agencies, and publishers through desktop, mobile, and social channels. It connects advertisers to consumers across digital advertising channels, including search advertising, social, display, video, digital audio, digital out of home (DOOH), and Connected TV (CTV) advertising. The company earns prime revenue from search advertising and display advertising services. It operates in the business segment of High Impact Advertising solutions. Geographically, the company generates a majority of its revenue from the United States and the rest from other regions.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.